CVRx, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CVRx, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $739.00K.
- CVRx, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was -$43.00K, a 100.47% decline year-over-year.
- CVRx, Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was -$179.00K, a 101.45% decline year-over-year.
- CVRx, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was -$45.00K, a 100.23% decline year-over-year.
- CVRx, Inc. stock issued during period, value, new issues for fiscal 2025 was $8.97M, a 72.41% decline from fiscal 2024.
- CVRx, Inc. stock issued during period, value, new issues for fiscal 2024 was $32.52M.
- CVRx, Inc. stock issued during period, value, new issues for fiscal 2021 was $133.16M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $739.00K 10-Q · filed 2026-08-06 | $472.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$43.00K 10-Q · filed 2026-05-12 | -$267.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $8.97M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$45.00K 10-Q · filed 2025-11-06 | $21.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $41.17M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $9.20M 10-Q · filed 2026-05-12 | $41.17M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $12.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $32.52M 10-K · filed 2026-02-13 |
| 2024-09-30 | $19.62M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$1.00K 10-Q · filed 2025-08-05 | |
| 2024-03-31 | $547.00K 10-Q · filed 2025-05-09 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $133.16M 10-K · filed 2023-02-10 |
| 2021-09-30 | $133.16M 10-Q · filed 2022-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |